GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Inventory Turnover

Beximco Pharmaceuticals (DHA:BXPHARMA) Inventory Turnover : 0.46 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Beximco Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2023 was BDT6,013 Mil. Beximco Pharmaceuticals's Average Total Inventories for the quarter that ended in Dec. 2023 was BDT13,174 Mil. Beximco Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.46.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Beximco Pharmaceuticals's Days Inventory for the three months ended in Dec. 2023 was 199.94.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Beximco Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.21.


Beximco Pharmaceuticals Inventory Turnover Historical Data

The historical data trend for Beximco Pharmaceuticals's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Inventory Turnover Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 2.05 2.14 1.99 1.82

Beximco Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.42 0.40 0.44 0.46

Beximco Pharmaceuticals Inventory Turnover Calculation

Beximco Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Jun. 2023 is calculated as

Inventory Turnover (A: Jun. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Jun. 2023 ) / ((Total Inventories (A: Jun. 2022 ) + Total Inventories (A: Jun. 2023 )) / count )
=21953.29 / ((11124.092 + 12953.018) / 2 )
=21953.29 / 12038.555
=1.82

Beximco Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover (Q: Dec. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Dec. 2023 ) / ((Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count )
=6012.518 / ((12953.018 + 13394.762) / 2 )
=6012.518 / 13173.89
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beximco Pharmaceuticals  (DHA:BXPHARMA) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Beximco Pharmaceuticals's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory =Average Total Inventories (Q: Dec. 2023 )/Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=13173.89/6012.518*365 / 4
=199.94

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Beximco Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=13173.89 / 10904.211
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Beximco Pharmaceuticals Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines